SerpinB2 (PAI-2) Modulates Proteostasis via Binding Misfolded Proteins and Promotion of Cytoprotective Inclusion Formation

PLoS One. 2015 Jun 17;10(6):e0130136. doi: 10.1371/journal.pone.0130136. eCollection 2015.

Abstract

SerpinB2 (PAI-2), a member of the clade B family of serine protease inhibitors, is one of the most upregulated proteins following cellular stress. Originally described as an inhibitor of urokinase plasminogen activator, its predominant cytoplasmic localisation suggests an intracellular function. SerpinB2 has been reported to display cytoprotective properties in neurons and to interact with intracellular proteins including components of the ubiquitin-proteasome system (UPS). In the current study we explored the potential role of SerpinB2 as a modulator of proteotoxic stress. Initially, we transiently transfected wild-type SerpinB2 and SerpinB2-/- murine embryonic fibroblasts (MEFs) with Huntingtin exon1-polyglutamine (fused C-terminally to mCherry). Inclusion body formation as result of Huntingtin aggregation was evident in the SerpinB2 expressing cells but significantly impaired in the SerpinB2-/- cells, the latter concomitant with loss in cell viability. Importantly, recovery of the wild-type phenotype and cell viability was rescued by retroviral transduction of SerpinB2 expression. SerpinB2 modestly attenuated Huntingtin and amyloid beta fibril formation in vitro and was able to bind preferentially to misfolded proteins. Given the modest chaperone-like activity of SerpinB2 we tested the ability of SerpinB2 to modulate UPS and autophagy activity using a GFP reporter system and autophagy reporter, respectively. Activity of the UPS was reduced and autophagy was dysregulated in SerpinB2-/- compared to wild-type MEFs. Moreover, we observed a non-covalent interaction between ubiquitin and SerpinB2 in cells using GFP-pulldown assays and bimolecular fluorescence complementation. We conclude that SerpinB2 plays an important role in proteostasis as its loss leads to a proteotoxic phenotype associated with an inability to compartmentalize aggregating proteins and a reduced capacity of the UPS.

MeSH terms

  • Amyloid beta-Peptides / chemistry
  • Animals
  • Cytoprotection / drug effects*
  • Exons / genetics
  • Female
  • Fibroblasts / cytology
  • Fibroblasts / drug effects
  • Fibroblasts / metabolism
  • Homeostasis / drug effects*
  • Humans
  • Inclusion Bodies / drug effects*
  • Inclusion Bodies / metabolism*
  • Mice
  • Peptides / metabolism
  • Plasminogen Activator Inhibitor 2 / metabolism*
  • Plasminogen Activator Inhibitor 2 / pharmacology*
  • Pregnancy
  • Protein Aggregates
  • Protein Binding
  • Protein Folding / drug effects*
  • Protein Multimerization / drug effects
  • Protein Structure, Secondary
  • Serotonin Plasma Membrane Transport Proteins / genetics
  • Serotonin Plasma Membrane Transport Proteins / metabolism
  • Stress, Physiological / drug effects
  • Ubiquitin / metabolism

Substances

  • Amyloid beta-Peptides
  • Peptides
  • Plasminogen Activator Inhibitor 2
  • Protein Aggregates
  • Serotonin Plasma Membrane Transport Proteins
  • Slc6a4 protein, mouse
  • Ubiquitin
  • polyglutamine

Grants and funding

These authors have no support or funding to report.